[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352460-105":59,"doc-detail-352460-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","nanotechnology-assisted-molecular-profiling-emerging-advances-in-circulating-tumor-dna-detection","Nanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection","","Tumor-derived circulating cell-free DNA (ctDNA) functions as a key biomarker for non-invasive cancer diagnosis, treatment monitoring, and prognostic assessment. Low abundance, high fragmentation, and rapid degradation constrain assay sensitivity, specificity, and analytical reliability. Nanotechnology-driven progress improves ctDNA analysis through selective enrichment nanomaterials, nano-enabled signal amplification, and integrated methods including CRISPR-based detection, microfluidics, and nanopore technologies. Nanostructure-based decoding of methylation, fragmentation, and multi-omics signatures, together with increasing AI integration, supports earlier detection and real-time therapeutic evaluation, while clinical translation challenges and future directions emphasize standardization, biocompatibility, automation, and regulatory readiness.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/nanotechnology-assisted-molecular-profiling-emerging-advances-in-circulating-tumor-dna-detection/352460/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/nanotechnology-assisted-molecular-profiling-emerging-advances-in-circulating-tumor-dna-detection/352460.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is ctDNA important for cancer diagnosis and monitoring?","Question",{"text":112,"@type":113},"ctDNA serves as a pivotal biomarker for non-invasive cancer diagnosis, treatment monitoring, and prognostic evaluation, enabling dynamic tracking of tumor evolution.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What technical challenges limit accurate ctDNA detection?",{"text":117,"@type":113},"ctDNA concentration in plasma is very low and masked by abundant background cell-free DNA; ctDNA also shows high heterogeneity in length, methylation, mutation spectra, and fragmentation, complicating detection.",{"name":119,"@type":110,"acceptedAnswer":120},"How does nanotechnology improve ctDNA detection?",{"text":121,"@type":113},"Nanomaterials enhance enrichment, recognition, and signal amplification using tunable properties and surface functionalization. They also support integrated platforms such as CRISPR-based detection, microfluidics, and nanopore sequencing.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352460,1790470784,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nNanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection  \nJiayi Kang 1–3 , *, Xing Ke 3 , *, Yanan Zhao 1 , Yunlan Zhou 1 , 3  \n1College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2DNA Molecular Materials and Biomedical Laboratory, Institute of Molecular Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 3Department of Clinical Laboratory, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Yunlan Zhou; Yanan Zhao, Email [cloudsgrace@shsmu.edu.cn](cloudsgrace@shsmu.edu.cn); [ynzhao@shsmu.edu.cn](ynzhao@shsmu.edu.cn)  \n\n| Abstract: Tumor-derived circulating cell-free DNA (ctDNA) has emerged as a pivotal biomarker for non-invasive cancer diagnosis, treatment monitoring, and prognostic evaluation. However, its inherently low abundance, high fragmentation, and rapid degradation impose stringent requirements on assay sensitivity, specificity, and analytical robustness. Rapid advances in nanotechnology have significantly accelerated progress in ctDNA detection. This review summarizes recent nanotechnology-assisted strategies for ctDNA analysis, including surface-engineered nanomaterials for selective enrichment, nano-enabled signal amplification modalities, and integrated platforms such as CRISPR-based detection, microfluidics and nanopore technologies. We further highlight nanostructurebased approaches for decoding methylation, fragmentation profiles, and multi-omics signatures, focusing on their potential to enhance early cancer detection and real-time therapeutic assessment. Moreover, increasing incorporation of artificial intelligence (AI) which spans nanostructure characterization, aptamer and probe design, multi-omics data integration, and algorithm development is reshaping the landscape of nano-assisted liquid biopsy. Finally, current challenges and future perspectives concerning the clinical translation of nanotechnology-assisted ctDNA detection are presented, emphasizing standardization, biocompatibility, automation, and regulatory readiness. Overall, this review provides a comprehensive outlook on how converging nanotechnology and AI innovations are advancing ctDNA-based precision oncology.\u003Cbr>Keywords: nanomaterials, circulating tumor DNA, multi-omics, machine learning, cancer diagnostics |\n| --- |\n| Introduction\u003Cbr>Circulating tumor DNA (ctDNA), released into the bloodstream by apoptotic and necrotic tumor cells, has emerged asa promising biomarker for non-invasive liquid biopsy.1 Compared with conventional tissue biopsies, ctDNA analysis offers significant advantages, including minimal invasiveness, dynamic monitoring of tumor evolution, and the potential to guide personalized therapy.2 Conventionally, the primary methodologies for ctDNA analysis can be broadly divided into PCR-based methods and sequencing-based strategies. However, the clinical translation of ctDNA detection still faces critical challenges.3 The concentration ofctDNA in plasma is extremely low and often obscured by abundant background cell-free DNA (cfDNA) derived from normal cells. Furthermore, ctDNA exhibits high heterogeneity in length, methylation patterns, mutation spectra, and high fragmentation, making its accurate detection more challenging.4\u003Cbr>Nanotechnology provides unique opportunities to overcome these barriers.5 Owing to their high surface-to-volume ratio, versatile surface chemistry, and tunable physicochemical properties, nanomaterials have been widely utilized to enhance ctDNA enrichment, recognition, and signal amplification.6 The continual optimization and surface functionalization of nanomaterials have led to the development of more efficient and specific p","cbCainQm2EhaaAYX","https://ap.wps.com/l/cbCainQm2EhaaAYX","pdf",13903368,29,"English","# Abstract\n# Introduction","[{\"question\":\"Why is ctDNA important for cancer diagnosis and monitoring?\",\"answer\":\"ctDNA serves as a pivotal biomarker for non-invasive cancer diagnosis, treatment monitoring, and prognostic evaluation, enabling dynamic tracking of tumor evolution.\"},{\"question\":\"What technical challenges limit accurate ctDNA detection?\",\"answer\":\"ctDNA concentration in plasma is very low and masked by abundant background cell-free DNA; ctDNA also shows high heterogeneity in length, methylation, mutation spectra, and fragmentation, complicating detection.\"},{\"question\":\"How does nanotechnology improve ctDNA detection?\",\"answer\":\"Nanomaterials enhance enrichment, recognition, and signal amplification using tunable properties and surface functionalization. They also support integrated platforms such as CRISPR-based detection, microfluidics, and nanopore sequencing.\"}]","Nanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection | PDF",1790099783,73,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb6413f03773e05d0731cac17089de12.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6a0776c83ebd89b5cbf769828e8cfef.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29063d6f59af25c663487d2d90e2f45d.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d97fd5b8f093541824e27e0b1a32b25f.webp",980,1268]